# Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas

> **NCT05479123** · PHASE4 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 52 (actual)

## Conditions studied

- Infantile Hemangioma

## Interventions

- **DRUG:** Propranolol three times a day
- **DRUG:** Propranolol twice a day
- **DRUG:** Timolol

## Key facts

- **NCT ID:** NCT05479123
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-23
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** due to lack of recruitment and follow up compliance
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05479123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05479123, "Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05479123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*